Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ultragenyx Pharmaceutical (RARE) Inventory Average (2018 - 2025)

Historic Inventory Average for Ultragenyx Pharmaceutical (RARE) over the last 8 years, with Q3 2025 value amounting to $49.3 million.

  • Ultragenyx Pharmaceutical's Inventory Average rose 1824.23% to $49.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.3 million, marking a year-over-year increase of 1824.23%. This contributed to the annual value of $39.5 million for FY2024, which is 3003.38% up from last year.
  • Ultragenyx Pharmaceutical's Inventory Average amounted to $49.3 million in Q3 2025, which was up 1824.23% from $46.3 million recorded in Q2 2025.
  • In the past 5 years, Ultragenyx Pharmaceutical's Inventory Average registered a high of $49.3 million during Q3 2025, and its lowest value of $12.8 million during Q1 2021.
  • In the last 5 years, Ultragenyx Pharmaceutical's Inventory Average had a median value of $27.4 million in 2023 and averaged $29.3 million.
  • Per our database at Business Quant, Ultragenyx Pharmaceutical's Inventory Average skyrocketed by 1129.53% in 2021 and then soared by 5682.14% in 2023.
  • Quarter analysis of 5 years shows Ultragenyx Pharmaceutical's Inventory Average stood at $15.7 million in 2021, then surged by 54.72% to $24.3 million in 2022, then soared by 35.29% to $32.9 million in 2023, then soared by 34.32% to $44.2 million in 2024, then grew by 11.72% to $49.3 million in 2025.
  • Its Inventory Average was $49.3 million in Q3 2025, compared to $46.3 million in Q2 2025 and $45.5 million in Q1 2025.